1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TRAVERE THERAPEUTICS INC

Travere Therapeutics Inc

XNAS: TVTX

Momentum Trap
Download real time

19.84 -1.03 (-4.94%)

287.50% Gain from 52W Low

1.3M XNAS Volume

XNAS 18 Mar, 2025 4:00 PM (EDT)

Watchlist

Portfolio

Share
12S
11W
6O
0T
1,760.6

Market Cap

Below industry Median
-5.5

PE TTM

Negative PE TTM
0

PEG TTM

29.8

Price to Book

High in industry
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Travere Therapeutics Inc

The latest disclosure was made by Eric M. Dube in Travere Therapeutics Inc where a trade of 11,375 Common Stock done at an average price of $24.0 was reported to US exchanges on Feb. 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 24.04 per share. 11 Feb 2025 11,375 419,173 (0%) 0% 24.0 273,455 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.23 per share. 11 Feb 2025 10,000 73,654 (0%) 0% 16.2 162,300 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2025 15,000 0 - - Employee stock option (right to buy)
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2025 10,000 0 - - Employee stock option (right to buy)
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2025 10,000 0 - - Employee stock option (right to buy)
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2025 10,000 0 - - Employee stock option (right to buy)
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 11 Feb 2025 9,244 54,410 (0%) 0% 25 231,100 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 11 Feb 2025 15,000 63,654 (0%) 0% 25 375,000 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.46 per share. 11 Feb 2025 15,000 78,654 (0%) 0% 15.5 231,900 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 11 Feb 2025 10,000 63,654 (0%) 0% 25 250,000 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.96 per share. 11 Feb 2025 10,000 73,654 (0%) 0% 18.0 179,600 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 11 Feb 2025 10,000 63,654 (0%) 0% 25 250,000 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.44 per share. 11 Feb 2025 10,000 73,654 (0%) 0% 17.4 174,400 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 11 Feb 2025 10,000 63,654 (0%) 0% 25 250,000 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 0 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 97,482 (0%) 0% - Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 23.53 per share. 10 Feb 2025 8,000 89,482 (0%) 0% 23.5 188,240 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 0 - - Performance-based restricted stock units
William E. Rote SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 23.53 per share. 10 Feb 2025 5,200 98,519 (0%) 0% 23.5 122,356 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 103,719 (0%) 0% - Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 0 - - Performance-based restricted stock units
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 23.53 per share. 10 Feb 2025 2,568 125,066 (0%) 0% 23.5 60,426 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 10 Feb 2025 3,074 127,634 (0%) 0% 25 76,850 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 130,708 (0%) 0% - Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 92,170 (0%) 0% - Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2025 8,000 0 - - Performance-based restricted stock units
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 23.53 per share. 10 Feb 2025 2,568 89,602 (0%) 0% 23.5 60,426 Common Stock
Roy D. Baynes Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.44 per share. 06 Feb 2025 10,000 41,000 (0%) 0% 17.4 174,400 Common Stock
Roy D. Baynes Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2025 10,000 0 - - Stock option (right to buy)
Roy D. Baynes Director Sale of securities on an exchange or to another person at price $ 22.00 per share. 06 Feb 2025 10,000 31,000 (0%) 0% 22 220,000 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 58,000 58,000 - - Employee stock option (right to buy)
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 21,500 98,433 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 19.78 per share. 31 Jan 2025 8,951 89,482 (0%) 0% 19.8 177,051 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 21,500 104,670 (0%) 0% 0 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 58,000 58,000 - - Employee stock option (right to buy)
William E. Rote SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 19.78 per share. 31 Jan 2025 8,951 95,719 (0%) 0% 19.8 177,051 Common Stock
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 260,000 260,000 - - Employee stock option (right to buy)
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 130,000 481,239 (1%) 0% 0 Common Stock
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 20.21 per share. 31 Jan 2025 50,691 430,548 (0%) 0% 20.2 1,024,343 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 20.12 per share. 31 Jan 2025 5,166 122,708 (0%) 0% 20.1 103,940 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 58,000 58,000 - - Employee stock option (right to buy)
Peter Heerma CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 21,500 127,874 (0%) 0% 0 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 13,000 67,002 (0%) 0% 0 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 20.12 per share. 31 Jan 2025 3,348 63,654 (0%) 0% 20.1 67,362 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 26,000 26,000 - - Employee stock option (right to buy)
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 20.11 per share. 31 Jan 2025 1,066 84,170 (0%) 0% 20.1 21,437 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 30,000 89,443 (0%) 0% 0 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 20.12 per share. 31 Jan 2025 4,207 85,236 (0%) 0% 20.1 84,645 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 100,000 100,000 - - Employee stock option (right to buy)
Christopher Cline CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 58,000 58,000 - - Employee stock option (right to buy)
Christopher Cline CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 21,500 95,230 (0%) 0% 0 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 20.12 per share. 31 Jan 2025 5,192 90,038 (0%) 0% 20.1 104,463 Common Stock
Roy D. Baynes Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jan 2025 16,000 0 - - Stock option (right to buy)
Roy D. Baynes Director Sale of securities on an exchange or to another person at price $ 20.00 per share. 23 Jan 2025 16,000 31,000 (0%) 0% 20 320,000 Common Stock
Roy D. Baynes Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.50 per share. 23 Jan 2025 16,000 47,000 (0%) 0% 17.5 280,000 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 19.46 per share. 22 Jan 2025 2,437 76,933 (0%) 0% 19.5 47,424 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 19.46 per share. 22 Jan 2025 2,437 83,170 (0%) 0% 19.5 47,424 Common Stock
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 19.46 per share. 22 Jan 2025 10,736 351,239 (0%) 0% 19.5 208,923 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 18.94 per share. 22 Jan 2025 1,584 106,374 (0%) 0% 18.9 30,002 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 18.94 per share. 22 Jan 2025 925 54,002 (0%) 0% 18.9 17,520 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 18.94 per share. 22 Jan 2025 865 73,730 (0%) 0% 18.9 16,384 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 19.10 per share. 03 Jan 2025 2,066 59,883 (0%) 0% 19.1 39,461 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 18.76 per share. 03 Jan 2025 440 59,443 (0%) 0% 18.8 8,254 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Dec 2024 15,000 0 - - Employee stock option (right to buy)
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 17.22 per share. 26 Dec 2024 15,000 54,927 (0%) 0% 17.2 258,278 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.67 per share. 26 Dec 2024 15,000 69,927 (0%) 0% 12.7 190,050 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.67 per share. 25 Nov 2024 15,000 67,017 (0%) 0% 12.7 190,050 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2024 15,000 15,000 - - Employee stock option (right to buy)
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 18.30 per share. 25 Nov 2024 12,090 54,927 (0%) 0% 18.3 221,258 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.48 per share. 04 Oct 2024 40,000 91,000 (0%) 0% 10.5 419,200 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2024 40,000 0 - - Stock option (right to buy)
Gary A. Lyons Director Sale of securities on an exchange or to another person at price $ 15.15 per share. 04 Oct 2024 18,821 51,000 (0%) 0% 15.2 285,227 Common Stock
Gary A. Lyons Director Sale of securities on an exchange or to another person at price $ 14.35 per share. 04 Oct 2024 21,179 69,821 (0%) 0% 14.3 303,874 Common Stock
Jeffrey A. Meckler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2024 40,000 0 - - Stock option (right to buy)
Jeffrey A. Meckler Director Sale of securities on an exchange or to another person at price $ 14.06 per share. 30 Sep 2024 40,000 81,000 (0%) 0% 14.1 562,324 Common Stock
Jeffrey A. Meckler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.48 per share. 30 Sep 2024 40,000 121,000 (0%) 0% 10.5 419,200 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 12.98 per share. 10 Sep 2024 684 61,949 (0%) 0% 13.0 8,878 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 6,750 83,020 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 11.52 per share. 05 Sep 2024 4,387 78,633 (0%) 0% 11.5 50,538 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 11.52 per share. 05 Sep 2024 4,387 84,455 (0%) 0% 11.5 50,538 Common Stock
William E. Rote SENIOR VICE PRESIDENT, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 6,750 88,842 (0%) 0% 0 Common Stock
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 11.52 per share. 05 Sep 2024 21,125 361,975 (0%) 0% 11.5 243,360 Common Stock
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 32,500 383,100 (0%) 0% 0 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 11.52 per share. 05 Sep 2024 2,191 107,958 (0%) 0% 11.5 25,240 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 6,750 110,149 (0%) 0% 0 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 6,750 64,824 (0%) 0% 0 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 11.52 per share. 05 Sep 2024 2,191 62,633 (0%) 0% 11.5 25,240 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 11.52 per share. 05 Sep 2024 2,490 74,595 (0%) 0% 11.5 28,685 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 6,750 77,085 (0%) 0% 0 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 9.51 per share. 04 Sep 2024 514 70,335 (0%) 0% 9.5 4,888 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 51,000 (0%) 0% 0 Common Stock
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 28,875 (0%) 0% 0 Common Stock
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 49,000 (0%) 0% 0 Common Stock
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 28,875 (0%) 0% 0 Common Stock
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 22,250 (0%) 0% 0 Common Stock
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 81,000 (0%) 0% 0 Common Stock
Sandra E. Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 23,500 (0%) 0% 0 Common Stock
Sandra E. Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 19,500 19,500 - - Stock option (right to buy)
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 6,500 31,000 (0%) 0% 0 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 6.74 per share. 11 Apr 2024 54 70,849 (0%) 0% 6.7 364 Common Stock
William Rote E. SENIOR VICE PRESIDENT, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 25,000 85,484 (0%) 0% 0 Common Stock
Inrig Jula CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 2,174 58,074 (0%) 0% 8.5 18,547 Common Stock
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 1,000 54,837 (0%) 0% 0 Common Stock
Reed E. Elizabeth SVP, GC & CORPORATE SECRETARY Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 65,000 65,000 - - Employee stock option (right to buy)
William Rote E. SENIOR VICE PRESIDENT, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 65,000 65,000 - - Employee stock option (right to buy)
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 2,820 52,017 (0%) 0% 8.5 24,058 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 65,000 65,000 - - Employee stock option (right to buy)
Reed Elizabeth E. SVP, GC & CORPORATE SECRETARY Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 25,000 81,034 (0%) 0% 0 Common Stock
M. Dube Eric Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 8.86 per share. 31 Jan 2024 10,016 350,600 (0%) 0% 8.9 88,742 Common Stock
Heerma Peter CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 25,000 103,698 (0%) 0% 0 Common Stock
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 12,500 53,837 (0%) 0% 0 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 65,000 65,000 - - Employee stock option (right to buy)
Cline Christopher CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 25,000 74,721 (0%) 0% 0 Common Stock
Dube Eric M. Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 360,000 360,000 - - Employee stock option (right to buy)
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 135,000 369,722 (0%) 0% 0 Common Stock
Dube M. Eric Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 9,106 360,616 (0%) 0% 8.5 77,693 Common Stock
Elizabeth E. Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 2,174 78,860 (0%) 0% 8.5 18,548 Common Stock
E. Rote William SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 8.86 per share. 31 Jan 2024 2,590 80,720 (0%) 0% 8.9 22,947 Common Stock
E. Elizabeth Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 8.86 per share. 31 Jan 2024 2,590 76,270 (0%) 0% 8.9 22,947 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 25,000 60,248 (0%) 0% 0 Common Stock
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 25,000 25,000 - - Employee stock option (right to buy)
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 4,195 99,503 (0%) 0% 8.5 35,789 Common Stock
Christopher Cline CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 3,818 70,903 (0%) 0% 8.5 32,573 Common Stock
William Rote E. SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 8.53 per share. 31 Jan 2024 2,174 83,310 (0%) 0% 8.5 18,548 Common Stock
Jula Inrig CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 91,000 91,000 - - Employee stock option (right to buy)
Cline Christopher CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 9.07 per share. 23 Jan 2024 853 49,721 (0%) 0% 9.1 7,735 Common Stock
E. Elizabeth Reed SVP, GC & CORPORATE SECRETARY Sale of securities on an exchange or to another person at price $ 8.96 per share. 23 Jan 2024 2,062 56,034 (0%) 0% 9.0 18,476 Common Stock
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 9.07 per share. 23 Jan 2024 910 41,337 (0%) 0% 9.1 8,252 Common Stock
Rote William E. SENIOR VICE PRESIDENT, R&D Sale of securities on an exchange or to another person at price $ 8.96 per share. 23 Jan 2024 2,062 60,484 (0%) 0% 9.0 18,476 Common Stock
Peter Heerma CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 9.07 per share. 23 Jan 2024 1,559 78,698 (0%) 0% 9.1 14,138 Common Stock
Eric M. Dube Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 8.96 per share. 23 Jan 2024 7,873 234,722 (0%) 0% 9.0 70,542 Common Stock
Jula Inrig Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.48 per share. 03 Jan 2024 2,069 35,688 (0%) 0% 9.5 19,613 Common Stock
Inrig Jula Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.17 per share. 03 Jan 2024 440 35,248 (0%) 0% 9.2 4,035 Common Stock
Sandra E. Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 13,500 13,500 - - Stock option (right to buy)
Sandra E. Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 4,500 17,000 (0%) 0% 0 Common Stock
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 4,500 24,500 (0%) 0% 0 Common Stock
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 13,500 13,500 - - Stock option (right to buy)
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 16.59 per share. 10 May 2023 825 56,611 (0%) 0% 16.6 13,687 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 16.59 per share. 10 May 2023 825 59,211 (0%) 0% 16.6 13,687 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 16.12 per share. 10 May 2023 122 42,247 (0%) 0% 16.1 1,967 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 16.59 per share. 10 May 2023 436 42,369 (0%) 0% 16.6 7,233 Common Stock
Christopher Cline Chief Financial Officer Sale of securities on an exchange or to another person at price $ 16.59 per share. 10 May 2023 455 51,031 (0%) 0% 16.6 7,548 Common Stock
Christopher Cline Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.49 per share. 11 Apr 2023 47 51,486 (0%) 0% 21.5 1,010 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 22.25 per share. 31 Jan 2023 2,590 57,436 (0%) 0% 22.3 57,628 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 6,750 6,750 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 20,250 60,026 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 54,500 54,500 - - Employee stock option (right to buy)
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 22.25 per share. 31 Jan 2023 2,590 60,036 (0%) 0% 22.3 57,628 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 54,500 54,500 - - Employee stock option (right to buy)
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 6,750 6,750 - - Performance-based restricted stock units
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 20,250 62,626 (0%) 0% 0 Common Stock
Eric M. Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 260,000 260,000 - - Employee stock option (right to buy)
Eric M. Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 22.25 per share. 31 Jan 2023 8,196 237,150 (0%) 0% 22.3 182,361 Common Stock
Eric M. Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 97,500 245,346 (0%) 0% 0 Common Stock
Eric M. Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 32,500 32,500 - - Performance-based restricted stock units
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 21.75 per share. 31 Jan 2023 1,779 82,069 (0%) 0% 21.8 38,697 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 54,500 54,500 - - Employee stock option (right to buy)
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 6,750 6,750 - - Performance-based restricted stock units
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 20,250 83,848 (0%) 0% 0 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 20,000 20,000 - - Employee stock option (right to buy)
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 21.75 per share. 31 Jan 2023 1,671 43,165 (0%) 0% 21.8 36,348 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 10,000 44,836 (0%) 0% 0 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 22.42 per share. 31 Jan 2023 360 42,805 (0%) 0% 22.4 8,071 Common Stock
Jula Inrig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 54,500 54,500 - - Employee stock option (right to buy)
Jula Inrig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 20,250 37,757 (0%) 0% 0 Common Stock
Jula Inrig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 6,750 6,750 - - Performance-based restricted stock units
Christopher Cline Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 6,750 6,750 - - Performance-based restricted stock units
Christopher Cline Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 54,500 54,500 - - Employee stock option (right to buy)
Christopher Cline Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.75 per share. 31 Jan 2023 1,588 51,533 (0%) 0% 21.8 34,542 Common Stock
Christopher Cline Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 20,250 53,121 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 21.50 per share. 24 Jan 2023 2,062 39,776 (0%) 0% 21.5 44,333 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 21.50 per share. 24 Jan 2023 2,062 42,376 (0%) 0% 21.5 44,333 Common Stock
Eric M. Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.50 per share. 24 Jan 2023 6,442 147,846 (0%) 0% 21.5 138,503 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 21.90 per share. 24 Jan 2023 1,550 63,598 (0%) 0% 21.9 33,952 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 21.63 per share. 24 Jan 2023 192 34,836 (0%) 0% 21.6 4,153 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 21.90 per share. 24 Jan 2023 905 35,028 (0%) 0% 21.9 19,823 Common Stock
Christopher Cline Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.90 per share. 24 Jan 2023 852 32,871 (0%) 0% 21.9 18,663 Common Stock
Eric M. Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.75 per share. 05 Jan 2023 5,625 154,288 (0%) 0% 20.8 116,719 Common Stock
Jula Inrig Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.75 per share. 04 Jan 2023 442 17,507 (0%) 0% 20.8 9,172 Common Stock
Jula Inrig Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.75 per share. 04 Jan 2023 2,051 17,949 (0%) 0% 20.7 42,558 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 25.68 per share. 04 Oct 2022 3,042 65,148 (0%) 0% 25.7 78,119 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 28.00 per share. 13 Sep 2022 349 35,933 (0%) 0% 28 9,772 Common Stock
Christopher Cline Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 9,840 9,840 - - Performance-based restricted stock units
Christopher Cline Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 5,000 33,723 (0%) 0% 0 Common Stock
Christopher Cline Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 48,000 48,000 - - Employee Stock option (right to buy)
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 40,000 (0%) 0% 0 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 17,875 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 21.93 per share. 11 May 2022 2,575 146,919 (0%) 0% 21.9 56,457 Common Stock
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 38,000 (0%) 0% 0 Common Stock
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 17,875 (0%) 0% 0 Common Stock
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 11,250 (0%) 0% 0 Common Stock
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 70,000 (0%) 0% 0 Common Stock
Sandra Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 12,500 (0%) 0% 0 Common Stock
Sandra Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 9,000 9,000 - - Stock option (right to buy)
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2022 3,000 20,000 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 21.52 per share. 11 May 2022 813 43,672 (0%) 0% 21.5 17,493 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 21.93 per share. 11 May 2022 750 44,485 (0%) 0% 21.9 16,448 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 21.51 per share. 10 May 2022 1,050 41,838 (0%) 0% 21.5 22,584 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 21.51 per share. 10 May 2022 900 42,888 (0%) 0% 21.5 19,359 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.51 per share. 10 May 2022 1,375 35,655 (0%) 0% 21.5 29,576 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.51 per share. 10 May 2022 825 37,030 (0%) 0% 21.5 17,746 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 21.51 per share. 10 May 2022 436 36,178 (0%) 0% 21.5 9,378 Common Stock
Sandra Calvin SVP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 21.92 per share. 10 May 2022 445 35,733 (0%) 0% 21.9 9,756 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 27.84 per share. 10 Feb 2022 4,832 159,913 (0%) 0% 27.8 134,523 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 9,840 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 45,138 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 27.40 per share. 31 Jan 2022 1,350 43,788 (0%) 0% 27.4 36,990 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 39,360 39,360 - - Employee stock option (right to buy)
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 8,000 8,000 - - Performance-based restricted stock units
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 8,000 8,000 - - Performance-based restricted stock units
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 9,840 - - Performance-based restricted stock units
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 39,360 39,360 - - Employee stock option (right to buy)
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 27.40 per share. 31 Jan 2022 1,238 37,855 (0%) 0% 27.4 33,921 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 39,093 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 27.40 per share. 31 Jan 2022 1,125 45,235 (0%) 0% 27.4 30,825 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 8,000 8,000 - - Performance-based restricted stock units
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 9,840 - - Performance-based restricted stock units
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 39,360 39,360 - - Employee stock option (right to buy)
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 46,360 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 37,848 37,848 - - Performance-based restricted stock units
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 169,552 169,552 - - Employee stock option (right to buy)
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 27.40 per share. 31 Jan 2022 4,813 164,745 (0%) 0% 27.4 131,876 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 37,848 169,558 (0%) 0% 0 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 39,360 39,360 - - Employee stock option (right to buy)
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 68,422 (0%) 0% 0 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 8,000 8,000 - - Performance-based restricted stock units
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 27.40 per share. 31 Jan 2022 1,125 67,297 (0%) 0% 27.4 30,825 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 9,840 9,840 - - Performance-based restricted stock units
Sandra Calvin VP, Corp Controller and CAO Sale of securities on an exchange or to another person at price $ 26.51 per share. 31 Jan 2022 798 36,614 (0%) 0% 26.5 21,152 Common Stock
Sandra Calvin VP, Corp Controller and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 17,500 17,500 - - Employee stock option (right to buy)
Sandra Calvin VP, Corp Controller and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 8,750 37,412 (0%) 0% 0 Common Stock
Jula Inrig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 8,000 8,000 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 24.98 per share. 24 Jan 2022 2,250 35,298 (0%) 0% 25.0 56,205 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 24.98 per share. 24 Jan 2022 2,063 29,253 (0%) 0% 25.0 51,534 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 24.98 per share. 24 Jan 2022 1,875 36,520 (0%) 0% 25.0 46,838 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 24.98 per share. 24 Jan 2022 7,873 131,710 (0%) 0% 25.0 196,668 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 24.98 per share. 24 Jan 2022 1,875 58,582 (0%) 0% 25.0 46,838 Common Stock
Sandra Calvin VP, Corp Controller and CAO Sale of securities on an exchange or to another person at price $ 24.58 per share. 24 Jan 2022 934 28,662 (0%) 0% 24.6 22,955 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 27.40 per share. 10 Jan 2022 5,000 37,548 (0%) 0% 27.4 137,000 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2022 5,000 42,548 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2022 7,500 38,816 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 27.40 per share. 10 Jan 2022 7,500 31,316 (0%) 0% 27.4 205,500 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 27.40 per share. 10 Jan 2022 2,500 38,395 (0%) 0% 27.4 68,500 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2022 5,000 40,895 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 29.84 per share. 04 Jan 2022 10,361 141,722 (0%) 0% 29.8 309,172 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 30.48 per share. 04 Jan 2022 2,139 139,583 (0%) 0% 30.5 65,197 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 30.43 per share. 04 Jan 2022 4,832 152,083 (0%) 0% 30.4 147,038 Common Stock
Jula Inrig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 80,000 80,000 - - Stock Option (Right to Buy)
Jula Inrig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 20,000 20,000 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 29.39 per share. 16 Nov 2021 31,800 149,494 (0%) 0% 29.4 934,602 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Nov 2021 10,000 70,000 - - Employee stock option (right to buy)
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 26.23 per share. 05 Nov 2021 10,000 161,794 (0%) 0% 26.2 262,300 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.23 per share. 05 Nov 2021 10,000 171,794 (0%) 0% 16.2 162,300 Common Stock
Stephen J. Aselage Director Gift of securities by or to the insider at price $ 0.00 per share. 01 Nov 2021 25,000 164,794 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Gift of securities by or to the insider at price $ 0.00 per share. 01 Nov 2021 25,000 25,000 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 30.00 per share. 01 Nov 2021 3,500 19,500 (0%) 0% 30 105,000 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 29.48 per share. 01 Nov 2021 5,000 23,000 (0%) 0% 29.5 147,400 Common Stock
Stephen J. Aselage Director Gift of securities by or to the insider at price $ 0.00 per share. 01 Nov 2021 3,000 28,000 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Gift of securities by or to the insider at price $ 0.00 per share. 01 Nov 2021 3,000 161,794 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.23 per share. 07 Oct 2021 60,000 249,794 (0%) 0% 16.2 973,800 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Oct 2021 60,000 80,000 - - Employee stock option (right to buy)
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 26.26 per share. 07 Oct 2021 32,000 189,794 (0%) 0% 26.3 840,320 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 26.23 per share. 07 Oct 2021 28,000 221,794 (0%) 0% 26.2 734,440 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 24.77 per share. 04 Oct 2021 3,058 60,457 (0%) 0% 24.8 75,746 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2021 4,500 38,955 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 17.12 per share. 13 Aug 2021 1,407 37,548 (0%) 0% 17.1 24,086 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.12 per share. 13 Aug 2021 1,407 31,316 (0%) 0% 17.1 24,085 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2021 4,500 32,723 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2021 4,500 49,021 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 17.12 per share. 13 Aug 2021 1,407 47,614 (0%) 0% 17.1 24,085 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2021 4,500 37,138 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 17.12 per share. 13 Aug 2021 1,407 35,731 (0%) 0% 17.1 24,085 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2021 17,500 164,751 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 17.12 per share. 13 Aug 2021 7,836 156,915 (0%) 0% 17.1 134,142 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 17.12 per share. 13 Aug 2021 1,407 63,515 (0%) 0% 17.1 24,086 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2021 4,500 64,922 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.81 per share. 28 Jul 2021 1,250 44,521 (0%) 0% 13.8 17,263 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 14.89 per share. 01 Jun 2021 4,782 152,031 (0%) 0% 14.9 71,204 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 14.35 per share. 01 Jun 2021 4,780 147,251 (0%) 0% 14.4 68,593 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 37,000 (0%) 0% 0 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 14,875 (0%) 0% 0 Common Stock
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Stephen J. Aselage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 189,794 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 35,000 (0%) 0% 0 Common Stock
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 14,875 (0%) 0% 0 Common Stock
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 8,250 (0%) 0% 0 Common Stock
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 67,000 (0%) 0% 0 Common Stock
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Sandra Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Sandra Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 9,500 (0%) 0% 0 Common Stock
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 3,000 17,000 (0%) 0% 0 Common Stock
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2021 9,000 9,000 - - Stock option (right to buy)
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 19.46 per share. 11 May 2021 1,625 34,455 (0%) 0% 19.5 31,623 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 19.14 per share. 11 May 2021 1,625 36,080 (0%) 0% 19.1 31,103 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 19.14 per share. 11 May 2021 2,000 30,223 (0%) 0% 19.1 38,280 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 19.46 per share. 11 May 2021 2,000 28,223 (0%) 0% 19.5 38,920 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 19.58 per share. 11 May 2021 2,146 186,794 (0%) 0% 19.6 42,023 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 19.46 per share. 11 May 2021 375 45,594 (0%) 0% 19.5 7,298 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 19.14 per share. 11 May 2021 375 45,969 (0%) 0% 19.1 7,178 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 19.46 per share. 11 May 2021 1,562 31,707 (0%) 0% 19.5 30,397 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 19.14 per share. 11 May 2021 1,563 33,269 (0%) 0% 19.1 29,916 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 26.23 per share. 16 Apr 2021 10,000 188,940 (0%) 0% 26.2 262,300 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.23 per share. 16 Apr 2021 10,000 198,940 (0%) 0% 16.2 162,300 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2021 10,000 140,000 - - Employee stock option (right to buy)
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Mar 2021 10,000 150,000 - - Employee stock option (right to buy)
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 27.56 per share. 17 Mar 2021 7,727 188,940 (0%) 0% 27.6 212,956 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 27.35 per share. 17 Mar 2021 10,000 196,667 (0%) 0% 27.4 273,500 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.23 per share. 17 Mar 2021 10,000 206,667 (0%) 0% 16.2 162,300 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 27.35 per share. 17 Feb 2021 1,250 36,082 (0%) 0% 27.4 34,188 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 28.67 per share. 17 Feb 2021 1,250 34,832 (0%) 0% 28.7 35,838 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 31.58 per share. 05 Feb 2021 2,250 37,705 (0%) 0% 31.6 71,055 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 31.41 per share. 05 Feb 2021 2,250 39,955 (0%) 0% 31.4 70,673 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 31.41 per share. 05 Feb 2021 2,250 34,473 (0%) 0% 31.4 70,673 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 31.58 per share. 05 Feb 2021 2,250 32,223 (0%) 0% 31.6 71,055 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 31.41 per share. 05 Feb 2021 1,125 47,469 (0%) 0% 31.4 35,336 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 31.58 per share. 05 Feb 2021 1,125 46,344 (0%) 0% 31.6 35,528 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 31.41 per share. 05 Feb 2021 2,250 39,582 (0%) 0% 31.4 70,673 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 31.58 per share. 05 Feb 2021 2,250 37,332 (0%) 0% 31.6 71,055 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 31.58 per share. 05 Feb 2021 4,813 156,813 (0%) 0% 31.6 151,995 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 31.41 per share. 05 Feb 2021 4,813 161,626 (0%) 0% 31.4 151,176 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 31.41 per share. 05 Feb 2021 1,125 60,469 (0%) 0% 31.4 35,336 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 31.58 per share. 05 Feb 2021 1,125 59,344 (0%) 0% 31.6 35,528 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 2,500 38,380 (0%) 0% 28.9 72,275 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 4,500 42,205 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 675 37,705 (0%) 0% 28.9 19,514 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 2,500 33,348 (0%) 0% 28.9 72,275 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 4,500 36,723 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 1,125 32,223 (0%) 0% 28.9 32,524 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 4,500 48,594 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 563 44,094 (0%) 0% 28.9 16,276 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 1,250 44,657 (0%) 0% 28.9 36,138 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 2,500 38,457 (0%) 0% 28.9 72,275 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 1,125 37,332 (0%) 0% 28.9 32,524 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 4,500 41,832 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 28.91 per share. 03 Feb 2021 2,406 148,939 (0%) 0% 28.9 69,557 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 17,500 166,439 (0%) 0% 0 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 4,500 61,594 (0%) 0% 0 Common Stock
Stephen J. Aselage Director Sale of securities on an exchange or to another person at price $ 30.75 per share. 02 Feb 2021 25,000 196,667 (0%) 0% 30.8 768,750 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.09 per share. 02 Feb 2021 25,000 221,667 (0%) 0% 10.1 252,250 Common Stock
Stephen J. Aselage Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2021 25,000 275,000 - - Employee stock option (right to buy)
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 30.75 per share. 02 Feb 2021 563 57,657 (0%) 0% 30.7 17,312 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 28.91 per share. 02 Feb 2021 563 57,094 (0%) 0% 28.9 16,276 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2021 5,000 44,055 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 675 40,880 (0%) 0% 30.7 20,756 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 2,500 41,555 (0%) 0% 30.8 76,875 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 1,125 35,848 (0%) 0% 30.8 34,594 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 2,500 36,973 (0%) 0% 30.8 76,875 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2021 5,000 39,473 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2021 5,000 47,720 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 1,250 46,470 (0%) 0% 30.8 38,438 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 563 45,907 (0%) 0% 30.7 17,312 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 2,500 40,957 (0%) 0% 30.8 76,875 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 1,125 43,457 (0%) 0% 30.8 34,594 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2021 5,000 44,582 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2021 15,000 160,079 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 30.75 per share. 31 Jan 2021 2,406 151,345 (0%) 0% 30.8 73,985 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 29.60 per share. 31 Jan 2021 6,328 153,751 (0%) 0% 29.6 187,282 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 57,500 57,500 - - Employee stock option (right to buy)
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 15,000 39,055 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 15,000 34,473 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 57,500 57,500 - - Employee stock option (right to buy)
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 15,000 42,720 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 57,500 57,500 - - Employee stock option (right to buy)
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 15,000 39,582 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 57,500 57,500 - - Employee stock option (right to buy)
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 212,660 212,660 - - Employee stock option (right to buy)
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 15,000 58,220 (0%) 0% 0 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2021 57,500 57,500 - - Employee stock option (right to buy)
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 26.65 per share. 05 Jan 2021 688 24,743 (0%) 0% 26.6 18,335 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 27.01 per share. 05 Jan 2021 688 24,055 (0%) 0% 27.0 18,583 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 26.65 per share. 05 Jan 2021 3,438 91,257 (0%) 0% 26.7 91,623 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 27.01 per share. 05 Jan 2021 3,438 87,819 (0%) 0% 27.0 92,860 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 26.02 per share. 15 Dec 2020 5,549 196,667 (0%) 0% 26.0 144,385 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 23.43 per share. 02 Dec 2020 7,891 202,216 (0%) 0% 23.4 184,849 Common Stock
Stephen Aselage Director Gift of securities by or to the insider at price $ 0.00 per share. 02 Dec 2020 3,000 210,107 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 22.72 per share. 23 Nov 2020 3,750 19,473 (0%) 0% 22.7 85,200 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 23.86 per share. 23 Nov 2020 3,750 23,223 (0%) 0% 23.9 89,475 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Nov 2020 7,500 26,973 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 23.98 per share. 16 Nov 2020 2,500 25,431 (0%) 0% 24.0 59,950 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 23.98 per share. 16 Nov 2020 7,500 19,473 (0%) 0% 24.0 179,813 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 23.96 per share. 16 Nov 2020 2,500 24,086 (0%) 0% 24.0 59,900 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 23.62 per share. 11 Nov 2020 2,500 27,931 (0%) 0% 23.6 59,046 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 5,000 30,431 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 23.61 per share. 11 Nov 2020 7,500 26,973 (0%) 0% 23.6 177,071 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 15,000 34,473 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 5,000 29,086 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 23.62 per share. 11 Nov 2020 2,500 26,586 (0%) 0% 23.6 59,056 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 23.00 per share. 05 Nov 2020 20,625 213,107 (0%) 0% 23 474,375 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 21.26 per share. 05 Nov 2020 2,500 233,732 (0%) 0% 21.3 53,150 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 18.90 per share. 02 Oct 2020 2,188 44,517 (0%) 0% 18.9 41,353 Common Stock
Peter Heerma Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 19.35 per share. 02 Oct 2020 2,188 42,329 (0%) 0% 19.4 42,338 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 18.48 per share. 23 Sep 2020 1,500 25,431 (0%) 0% 18.5 27,720 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.48 per share. 23 Sep 2020 1,500 19,473 (0%) 0% 18.5 27,720 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 18.48 per share. 23 Sep 2020 750 27,555 (0%) 0% 18.5 13,860 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 18.48 per share. 23 Sep 2020 1,500 24,086 (0%) 0% 18.5 27,720 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2020 3,000 28,431 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 18.59 per share. 18 Sep 2020 1,500 26,931 (0%) 0% 18.6 27,885 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.59 per share. 18 Sep 2020 1,500 20,973 (0%) 0% 18.6 27,885 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2020 3,000 22,473 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 18.59 per share. 18 Sep 2020 750 28,305 (0%) 0% 18.6 13,943 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2020 3,000 29,055 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2020 3,000 27,086 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 18.59 per share. 18 Sep 2020 1,500 25,586 (0%) 0% 18.6 27,885 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2020 3,000 105,500 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 19.29 per share. 18 Sep 2020 1,565 94,695 (0%) 0% 19.3 30,186 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 19.28 per share. 18 Sep 2020 9,240 96,260 (0%) 0% 19.3 178,133 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2020 25,000 102,500 (0%) 0% 0 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 19.68 per share. 05 Aug 2020 2,500 236,232 (0%) 0% 19.7 49,200 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.49 per share. 28 Jul 2020 870 26,055 (0%) 0% 20.5 17,826 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 20.00 per share. 25 Jun 2020 10,000 238,732 (0%) 0% 20 200,000 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 34,000 (0%) 0% 0 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Ron Squarer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 11,875 (0%) 0% 0 Common Stock
Stephen Aselage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Stephen Aselage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 248,732 (0%) 0% 0 Common Stock
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Timothy P. Coughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 32,000 (0%) 0% 0 Common Stock
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 11,875 (0%) 0% 0 Common Stock
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Jeffrey A. Meckler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 64,000 (0%) 0% 0 Common Stock
Sandra Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Sandra Poole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 6,500 (0%) 0% 0 Common Stock
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 3,000 14,000 (0%) 0% 0 Common Stock
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 9,000 9,000 - - Employee stock option (right to buy)
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 15.09 per share. 12 May 2020 3,062 245,732 (0%) 0% 15.1 46,206 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 17.16 per share. 12 May 2020 1,000 252,857 (0%) 0% 17.2 17,160 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 16.41 per share. 12 May 2020 4,063 248,794 (0%) 0% 16.4 66,674 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 16.98 per share. 12 May 2020 527 26,728 (0%) 0% 17.0 8,951 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 16.98 per share. 11 May 2020 527 25,431 (0%) 0% 17.0 8,951 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 17.16 per share. 11 May 2020 525 25,958 (0%) 0% 17.2 9,009 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 14.95 per share. 11 May 2020 525 26,483 (0%) 0% 15.0 7,849 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.16 per share. 11 May 2020 1,250 20,000 (0%) 0% 17.2 21,450 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 16.98 per share. 11 May 2020 527 19,473 (0%) 0% 17.0 8,951 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.95 per share. 11 May 2020 1,250 21,250 (0%) 0% 15.0 18,688 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 14.95 per share. 11 May 2020 813 24,833 (0%) 0% 14.9 12,154 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 16.98 per share. 11 May 2020 527 23,494 (0%) 0% 17.0 8,951 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 17.16 per share. 11 May 2020 812 24,021 (0%) 0% 17.2 13,934 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 15.88 per share. 05 May 2020 2,500 253,857 (0%) 0% 15.9 39,700 Common Stock
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2020 5,250 5,250 (0%) 0% 0 Common Stock
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2020 15,750 15,750 - - Stock Option (Right to Buy)
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 15.02 per share. 10 Mar 2020 3,500 27,008 (0%) 0% 15.0 52,570 Common Stock
Laura M. Clague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 15.02 per share. 10 Mar 2020 4,000 22,500 (0%) 0% 15.0 60,080 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 14.87 per share. 10 Mar 2020 3,250 25,646 (0%) 0% 14.9 48,328 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 3,500 30,508 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 4,000 26,500 (0%) 0% 0 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 15.36 per share. 05 Mar 2020 4,359 256,357 (0%) 0% 15.4 66,939 Common Stock
Stephen Aselage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 12,250 260,716 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.36 per share. 05 Mar 2020 1,790 27,255 (0%) 0% 15.4 27,487 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 5,000 29,045 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 3,250 28,896 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 16.55 per share. 14 Feb 2020 1,250 25,646 (0%) 0% 16.6 20,688 Common Stock
William E. Rote Senior Vice President, R&D Sale of securities on an exchange or to another person at price $ 16.72 per share. 14 Feb 2020 1,250 26,896 (0%) 0% 16.7 20,900 Common Stock
Stephen Aselage Director Sale of securities on an exchange or to another person at price $ 16.62 per share. 05 Feb 2020 2,500 248,466 (0%) 0% 16.6 41,550 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 27,008 (0%) 0% 0 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 10,000 10,000 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 9,000 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 55,000 55,000 - - Employee stock option (right to buy)
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 22,500 (0%) 0% 0 Common Stock
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 10,000 10,000 - - Performance-based restricted stock units
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 9,000 - - Performance-based restricted stock units
Laura M. Clague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 55,000 55,000 - - Employee stock option (right to buy)
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 22,500 (0%) 0% 0 Common Stock
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 10,000 10,000 - - Performance-based restricted stock units
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 9,000 - - Performance-based restricted stock units
Noah L. Rosenberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 55,000 55,000 - - Employee stock option (right to buy)
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 10,000 10,000 - - Performance-based restricted stock units
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 27,185 (0%) 0% 0 Common Stock
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 55,000 55,000 - - Employee stock option (right to buy)
William E. Rote Senior Vice President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 9,000 - - Performance-based restricted stock units
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 35,000 77,500 (0%) 0% 0 Common Stock
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 30,000 30,000 - - Performance-based restricted stock units
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 35,000 35,000 - - Performance-based restricted stock units
Eric Dube Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 300,000 300,000 - - Employee stock option (right to buy)
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 44,000 (0%) 0% 0 Common Stock
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 55,000 55,000 - - Employee stock option (right to buy)
Peter Heerma Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 9,000 9,000 - - Performance-based restricted stock units
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 15.14 per share. 07 Jan 2020 750 18,008 (0%) 0% 15.1 11,355 Common Stock
Elizabeth E. Reed SVP, GC & Corporate Secretary Sale of securities on an exchange or to another person at price $ 13.94 per share. 07 Jan 2020 750 18,758 (0%) 0% 13.9 10,455 Common Stock
Eric Dube Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.14 per share. 07 Jan 2020 3,750 42,500 (0%) 0% 15.1 56,775 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters